Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant (2012)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2011.12.034
- Assunto: MICROBIOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo possui acesso gratuito no site do editor (Bronze Open Access) -
ABNT
AMORIM, Jaime Henrique et al. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine, v. 30, n. 5, p. 837-845, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2011.12.034. Acesso em: 13 mar. 2026. -
APA
Amorim, J. H., Diniz, M. O., Cariri, F. A. M. O., Rodrigues, J. F., Bizerra, R. S. P., Gonçalves, A. J. S., et al. (2012). Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine, 30( 5), 837-845. doi:10.1016/j.vaccine.2011.12.034 -
NLM
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RSP, Gonçalves AJS, Alves AM de B, Ferreira LC de S. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant [Internet]. Vaccine. 2012 ; 30( 5): 837-845.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2011.12.034 -
Vancouver
Amorim JH, Diniz MO, Cariri FAMO, Rodrigues JF, Bizerra RSP, Gonçalves AJS, Alves AM de B, Ferreira LC de S. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant [Internet]. Vaccine. 2012 ; 30( 5): 837-845.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2011.12.034 - Evaluation of experimental conditions for quantification of LT produced by human derived enterotoxigenic Escherichia coli strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains based on intimin expression by recombinant Bacillus subtilis strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains
- Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules
- Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
- Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells
- Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors
- Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
- Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
- Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
